SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-460637
Filing Date
2012-11-08
Accepted
2012-11-08 16:47:03
Documents
11
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d398142d10q.htm 10-Q 626263
2 EX-31.1 d398142dex311.htm EX-31.1 10239
3 EX-31.2 d398142dex312.htm EX-31.2 10166
4 EX-32.1 d398142dex321.htm EX-32.1 3515
5 EX-32.2 d398142dex322.htm EX-32.2 3533
  Complete submission text file 0001193125-12-460637.txt   4153885

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bcrx-20120930.xml EX-101.INS 512095
7 XBRL TAXONOMY EXTENSION SCHEMA bcrx-20120930.xsd EX-101.SCH 48952
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bcrx-20120930_cal.xml EX-101.CAL 47598
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcrx-20120930_def.xml EX-101.DEF 111466
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcrx-20120930_lab.xml EX-101.LAB 349040
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcrx-20120930_pre.xml EX-101.PRE 237543
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 121190613
SIC: 2836 Biological Products, (No Diagnostic Substances)